female with cholecystitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Obstruction of the cystic duct, often by gallstones, leads to bile stasis, causing inflammation of the gallbladder wall due to the accumulation of bile and increased pressure.

• Secondary mechanism: Inflammatory response is further exacerbated by the release of inflammatory mediators and potential infection by gut bacteria, which can penetrate the gallbladder wall due to the compromised mucosal barrier.

• Key complication: If untreated, inflammation can lead to gallbladder necrosis or perforation, potentially resulting in peritonitis, a serious condition requiring urgent medical intervention.

Patient Profile

Demographics:

35-year-old female, office administrator

History:

• Key past medical history: History of gallstones, recurrent urinary tract infections

• Current medications: Oral contraceptive pill, ibuprofen as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain

• Key symptoms: Right upper quadrant pain, nausea, vomiting, fever, and jaundice

• Vital signs: Temperature 101.5°F, heart rate 110 bpm, blood pressure 130/85 mmHg, respiratory rate 22 breaths per minute

Section 1

As the patient continues to be monitored in the emergency department, her condition evolves, prompting further evaluation. The initial assessment reveals marked tenderness in the right upper quadrant upon palpation, accompanied by guarding and rebound tenderness, indicating potential peritoneal irritation. Her laboratory results return, showing elevated white blood cell count at 16,000/mm³, suggesting a significant inflammatory or infectious process. Liver function tests reveal elevated bilirubin and alkaline phosphatase, consistent with obstructive jaundice due to the gallstone. Additionally, an ultrasound of the abdomen confirms the presence of gallstones and reveals signs of gallbladder wall thickening, consistent with acute cholecystitis.

Despite the initiation of intravenous fluids and antibiotics, the patient's clinical status begins to deteriorate. Her fever spikes to 102.2°F, and she begins to exhibit signs of systemic involvement, including hypotension with a blood pressure drop to 100/70 mmHg and increased tachycardia at 120 bpm. Her respiratory rate rises to 26 breaths per minute, and she reports increasing shortness of breath. These changes raise concerns for developing sepsis or the possibility of gallbladder perforation leading to peritonitis. The interdisciplinary team is prompted to consider urgent surgical consultation for potential cholecystectomy and further imaging to rule out complications such as perforation or abscess formation.

This shift in the patient's status necessitates a reevaluation of her management plan, emphasizing the importance of swift diagnostic and therapeutic interventions to prevent further deterioration. Her rapid clinical changes also underscore the need for vigilant monitoring and reassessment, allowing for timely escalation of care if necessary. The healthcare team must now balance aggressive medical management with the potential need for surgical intervention, considering the risks and benefits in the context of her evolving condition.

Section 2

As the interdisciplinary team continues to monitor the patient's condition, new diagnostic results provide further insight into her evolving clinical status. A computed tomography (CT) scan of the abdomen is performed to assess for potential complications such as gallbladder perforation or abscess formation. The CT scan reveals a pericholecystic fluid collection, suggestive of a developing abscess, but no evidence of free air, which would indicate perforation. This finding aligns with the patient's rising inflammatory markers and persistent abdominal pain, further complicating her case of acute cholecystitis.

In response to these new diagnostic findings, the healthcare team decides to adjust the patient's management plan. Given the presence of the abscess and her deteriorating clinical picture, an interventional radiologist is consulted to perform a percutaneous cholecystostomy. This procedure aims to drain the abscess and alleviate the infectious burden, providing temporary relief while stabilizing her condition for potential surgical intervention. Concurrently, broad-spectrum antibiotics are escalated to cover gram-negative and anaerobic organisms commonly associated with biliary infections.

The patient's response to these interventions is closely monitored, with particular attention paid to her vital signs and laboratory parameters. Over the next 24 hours, her fever begins to subside, and her blood pressure stabilizes, improving to 110/75 mmHg, while her heart rate decreases to 100 bpm. However, her white blood cell count remains elevated, indicating ongoing infection. This response suggests partial improvement, but the team remains vigilant for any signs of further complications, such as recurrent abscess formation or septic shock. The patient is scheduled for a follow-up evaluation to determine the feasibility of a cholecystectomy once she is clinically stable. This ongoing assessment highlights the critical interplay between medical and surgical management in addressing complex cases of cholecystitis with complications.

Section 3

As the interdisciplinary team continues to assess the patient's response to the recent interventions, new complications arise that demand immediate attention. Within 48 hours post-procedure, the patient begins to exhibit signs of worsening jaundice, with increased yellowing of the skin and sclera. Her laboratory results reveal a significant elevation in bilirubin levels, now measuring at 5.8 mg/dL, alongside a rising alkaline phosphatase, which suggests the development of a bile duct obstruction. The patient's liver function tests, including AST and ALT, also show a notable increase, indicating hepatic stress.

In light of these findings, the team suspects the possibility of choledocholithiasis, or stones in the common bile duct, which may have been missed initially or developed as a complication from the inflamed gallbladder. An urgent endoscopic retrograde cholangiopancreatography (ERCP) is scheduled to both confirm the presence of any stones and provide therapeutic intervention through stone extraction or stent placement if necessary. This procedure is critical not only to relieve the obstruction but also to prevent further liver damage or potential cholangitis, a serious infection of the bile duct system.

The patient's clinical status is closely monitored during this period, with specific attention to her pain levels, which have localized more to the right upper quadrant, and her vital signs. Her blood pressure remains stable at 115/78 mmHg, and her heart rate is 98 bpm, but she continues to experience mild tachypnea with a respiratory rate of 22 breaths per minute. The team emphasizes the importance of maintaining adequate hydration and nutritional support, given the increased metabolic demands and reduced oral intake due to her discomfort. This evolving scenario presents an opportunity for the team to refine their clinical reasoning by integrating new diagnostic insights and tailoring the management plan to address both existing and emerging complications, ultimately aiming to stabilize the patient for definitive surgical intervention.

Section 4

The team proceeds with the scheduled ERCP, which confirms the presence of multiple stones in the common bile duct. During the procedure, the endoscopist successfully extracts the stones and places a temporary stent to ensure adequate bile drainage. Following the ERCP, the patient's jaundice shows signs of gradual improvement, and her bilirubin levels begin to decrease, measuring 4.5 mg/dL within 24 hours post-procedure. Despite this progress, her alkaline phosphatase remains elevated, indicating persistent hepatic stress. The team remains vigilant in monitoring her liver function tests, noting that AST and ALT levels are slowly trending downward, suggesting partial alleviation of the hepatic insult.

In the immediate period following the procedure, the patient reports a reduction in the intensity of her right upper quadrant pain. However, she experiences intermittent low-grade fevers, with temperatures peaking at 100.5°F (38.1°C), raising concern for a potential post-ERCP pancreatitis. Her vital signs include a stable blood pressure of 112/75 mmHg, heart rate of 102 bpm, and a respiratory rate of 20 breaths per minute. Given these developments, the team initiates a regimen of intravenous fluids to maintain hydration and reduce pancreatic inflammation, alongside close monitoring of her amylase and lipase levels to detect any further pancreatic involvement.

As the patient navigates this critical post-procedural phase, the interdisciplinary team emphasizes the importance of a multidisciplinary approach to address her evolving condition. Close collaboration with gastroenterology, hepatology, and nursing staff ensures comprehensive management of her care. The focus shifts to preventing further complications, such as cholangitis or recurrent pancreatitis, by optimizing her hydration status, adjusting her pain management plan, and ensuring timely follow-up imaging to assess for residual or recurrent biliary obstruction. With these strategies in place, the team aims to stabilize her condition and prepare for potential future surgical intervention to prevent recurrence of gallbladder-related complications.

Section 5

As the patient progresses through her post-ERCP recovery, the interdisciplinary team conducts a thorough assessment to evaluate her response to the interventions and detect any emerging complications. Over the next 48 hours, her clinical picture reveals a mix of improvements and new concerns. Her vital signs remain largely stable; her blood pressure holds at 110/70 mmHg, and her heart rate decreases slightly to 96 bpm, suggesting a positive response to hydration therapy. Her respiratory rate is steady at 20 breaths per minute, and oxygen saturation is maintained at 98% on room air. Despite these encouraging signs, her low-grade fever persists intermittently, now reaching peaks of 100.8°F (38.2°C).

The team notes a concerning trend in her laboratory results. While her bilirubin continues to decrease, now at 3.8 mg/dL, indicating improving bile flow, her amylase and lipase levels have risen significantly, with amylase at 300 U/L and lipase at 450 U/L, suggesting the onset of mild post-ERCP pancreatitis. In addition to these findings, her white blood cell count has elevated to 13,000/mm³, hinting at an underlying inflammatory or infectious process. The team prioritizes reinforcing her IV fluid therapy to counteract the pancreatic inflammation and adjusts her pain management to better control her abdominal discomfort.

During this critical phase, the team remains vigilant for signs of further complications, such as cholangitis or severe pancreatitis. They decide to initiate broad-spectrum antibiotics as a precautionary measure against potential infection, given the elevated white blood cell count and persistent fever. Frequent reassessment and communication with the patient and her family become paramount, as the team prepares for the possibility of additional imaging studies or surgical evaluations. The overarching goal is to stabilize her condition, ensure comprehensive care, and mitigate any further risks, setting the stage for a strategic, patient-centered recovery plan.